Related Experiment Video
Updated: Apr 4, 2026

10:41
Robotic D3 Partial Duodenal Resection with Primary Side-to-Side Anastomosis
Published on: December 15, 2023
2.9K
Laparoscopic Duhamel Procedure for Hirschsprung's Disease: Systematic Review and Meta-analysis.
Daniel W Scholfield1, Ashok Daya Ram1
1Department of Paediatric Surgery, Birmingham Children's Hospital , Birmingham, United Kingdom .
Summary
Laparoscopic Duhamel (LD) pull-through surgery for Hirschsprung
Area of Science:
- Pediatric Surgery
- Gastrointestinal Surgery
- Surgical Outcomes Research
Background:
- The Duhamel procedure, established in 1956, is a standard surgical approach for Hirschsprung's disease (HD).
- Laparoscopic techniques have been integrated into the Duhamel procedure, maintaining its core principles.
- This study evaluates the long-term efficacy of open Duhamel (OD) versus laparoscopic Duhamel (LD) for HD treatment.
Purpose of the Study:
- To compare long-term functional outcomes between open Duhamel (OD) and laparoscopic Duhamel (LD) procedures for Hirschsprung's disease (HD).
- To determine if the laparoscopic approach offers significant advantages over the traditional open method for HD treatment.
Main Methods:
- A systematic review of studies published between 1994 and 2014 assessing functional outcomes of OD and LD procedures.
- Meta-analysis of 11 articles including 456 patients (253 OD, 203 LD).
- Calculation of odds ratios for dichotomous variables and mean differences for continuous variables.
Main Results:
- Laparoscopic Duhamel (LD) showed a significantly lower incidence of soiling/incontinence (4% vs. 11%) and need for further surgery (14% vs. 25%) compared to Open Duhamel (OD).
- LD procedures resulted in shorter hospital stays and faster time to oral feeds than OD.
- Operative time was longer for LD, but there were no significant differences in enterocolitis or constipation rates between the two methods.
Conclusions:
- The meta-analysis indicates that laparoscopic Duhamel (LD) pull-through is superior to open Duhamel (OD) for treating Hirschsprung's disease (HD).
- Further high-quality evidence from prospective, randomized controlled trials is recommended to solidify these findings.

